1977.12 – 1982.12：同济医科大学医疗系本科，获医学学士学位
1985.9 – 1988.6：同济医科大学硕士生，获外科学硕士学位
1988.9 – 1991.6：同济医科大学博士生，获医学博士学位

1.2007-2010, “特异性T细胞NF-kappaB抑制联合DST诱导强免疫耐受及其机理”, 国家自然科学基金课题. 项目批准号：30772041
2.2007-2010, “Cre-loxP系统/SV40T/HSV-TK基因介导的可逆性永生化人源肝细胞的研制”, 湖北省自然科学基金重大项目，项目编号：2007ABD005
3.2011-2013, “创新的全TLR阻断剂诱导和维持耐受及其机理”，国家自然科学基金课题. 项目批准号：81072442

1. 2015-2019, “独创的MyD88抑制剂靶向防治GVHD的新策略及机理”，国家自然科学基金课题. 项目批准号：81471588（80万）
2. 2015-2016，横向课题，“HepAssis2?生物人工肝的研发”，联合研发单位:武汉仝干生物科技有限公司（第一期合同100万）

1.Robert Chin, Ping Zhou, Maria-Luisa Alegre, Yang Xin Fu. Confounding factors complicate conclusions in aly model. Nature Medicine, 2001 Nov; 7(11):1165-6. 2001.(IF 27.905)
2.Subudhi SK, Ping Zhou, Yerian LM, Chin RK, Lo JC, Anders RA, Sun Y, Chen L, Wang Y, Alegre ML*, Fu YX*. B7-H1 costimulation promotes T cell-mediated autoimmune diabetes and islet transplantation rejection. J. Clinical Investigation, 2004 Mar;113(5):694-700 (* co-last authors). (IF 12.015) 
3.Zhou Ping*, McNerney ME*, Lee KM*, Molinero L, Mashayekhi M, Guzior D, Sattar H, Kuppireddi S, Wang CR, Vinay Kumar*, Alegre ML*. Role of NK cell subsets in cardiac allograft rejection.Am. J. Transplant., 6:505-513, 2006 (*co-first and co-last authors). (IF 6.843)
4.Cheng-Biao Xue, Yong Liu, Chao Li, Yao Li, Tao Yang, Lin Xie, Ping Zhou(通讯作者). Powerful Protection against Renal Ischemia Reperfusion Injury by T Cell-specific Inhibition. Transplantation 2014 Feb., 97(4): 391-396. (IF3.781)
5.Lina Fu, Yue Zhang, Chao Li, Zhihong Wu, Qi Zhuo, Xia Huang, GuixingQiu, Ping Zhou (通讯作者)and Guang Yang (通讯作者). Skin tissue repair materials from bacterial cellulose by a multilayer fermentation method. Journal of Materials Chemistry 2012; 22, 12349–12357. (IF 5.099)
6.Shuai Xing, Jun Yang, Xue Zhang, Ping Zhou(通讯作者). Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation--a meta-analysis.Clinical biochemistry 2014 May;47(7-8):663-9 (IF: 2.275). (不俗论文)
7.Yong Liu, Yao Li, Liming Zhang, Mingqiang Li, Chao Li, Cheng-Biao Xie, Ping Zhou(通讯作者). NF-κB Downregulates Cbl-b through Binding and Suppressing Cbl-b Promoter in T Cell Activation. Journal of Immunology 2015 Apr 15; 194(8): 3778-83. 
8.Lin Xie, Liming Zhang, Mingqiang Li, Chao Li, Shuai Xing, Xue Zhang, Feng-Chao Jiang, Ping Zhou(通讯作者). A novel synthetic inhibitor of MyD88 ameliorates inflammatory microenvironment by targeting MyD88 homodimerization and completely prevents colitis-associated colorectal cancer. JNCI (Journal of National Cancer Institute) 2015, 108(4): djv364. First published online December 28, 2015. (IF 15)